Statements (75)
Predicate | Object |
---|---|
gptkbp:instanceOf |
patent
|
gptkbp:covers |
chemical composition
|
gptkbp:hasAbstract |
This patent describes a novel method.
|
gptkbp:hasAssignee |
Company XYZ
|
gptkbp:hasClaim |
20
composition of matter. method of synthesis. method of delivery. method of treatment. pharmaceutical formulation. |
gptkbp:hasContent |
US_5,678,901
|
gptkbp:hasDescription |
Detailed description of the invention.
|
gptkbp:hasFieldOfUse |
medical devices
pharmaceuticals biotechnology. therapeutics. |
gptkbp:hasFilingDate |
2004-02-06
|
gptkbp:hasInternationalClassification |
C07D 401/12
|
gptkbp:hasInventor |
gptkb:John_Doe
Jane_Smith |
gptkbp:hasLegalStatus |
gptkb:XYZ_Inc.
gptkb:XYZ_Corp. active active. active patent. XYZ_Corporation. |
gptkbp:hasPatentNumber |
6,789,148
|
gptkbp:hasPriorityDate |
2024-02-06
2003-02-06 2003-02-06. |
gptkbp:hasPublications |
2004-09-14
|
gptkbp:hasRelatedPatent |
gptkb:US_6,789,147
granted patent US_6,789,150. US_6,789,149. |
gptkbp:hasTechnicalField |
organic chemistry
medicinal chemistry. pharmaceutical chemistry. |
gptkbp:hasTechnology |
improved efficacy
enhanced stability. improved absorption. |
https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,148 C14
|
gptkbp:isAssignedTo |
gptkb:XYZ_Corp.
|
gptkbp:isCitedBy |
gptkb:US_7,123,456
gptkb:US_7,890,123 US_7,890,123. US_8,765,432. |
gptkbp:isCitedIn |
gptkb:US_8,765,432
gptkb:US_9,876,543 US_9,876,543. |
gptkbp:isExaminedBy |
gptkb:USPTO
patent office. patent examiner. USPTO. USPTO_examiner. |
gptkbp:isFiledIn |
gptkb:United_States
international patent office. |
gptkbp:isFiledUnder |
gptkb:John_Doe
utility patent patent law. utility patent law. Jane_Smith. John_Smith. |
gptkbp:isGranted |
true
|
gptkbp:isPartOf |
patent portfolio
patent family intellectual property. patent litigation. patent strategy. |
gptkbp:isPublishedIn |
USPTO database
patent journal |
gptkbp:isRelatedTo |
gptkb:US_6,789,147
gptkb:US_6,789,150 US_6,789,149 |
gptkbp:relatedTo |
method for manufacturing
|